Serina Therapeutics Inc
(SER)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 0 | 130 | 0 | -14 | 14 |
| Gross Profit | N/A | 130 | N/A | -14 | 14 |
| Operating Expenses | 6,392 | 5,695 | 5,858 | 5,535 | 5,326 |
| Operating Income | -6,392 | -5,565 | -5,858 | -5,549 | -5,312 |
| Interest Expense | 6 | 9 | 0 | 17 | 16 |
| Other Income | 1,803 | -888 | 1,036 | 2,814 | 6,711 |
| Pre-tax Income | -4,595 | -6,462 | -4,822 | -2,752 | 1,383 |
| Net Income Continuous | -4,595 | -6,462 | -4,822 | -2,752 | 1,383 |
| Minority Interests | -10 | -14 | -9 | -12 | -27 |
| Net Income | $-4,585 | $-6,448 | $-4,813 | $-2,740 | $1,410 |
| EPS Basic Total Ops | -0.45 | -0.66 | -0.49 | 3.10 | 0.16 |
| EPS Basic Continuous Ops | -0.44 | -0.65 | -0.49 | 3.09 | 0.16 |
| EPS Diluted Total Ops | -0.45 | -0.66 | -0.49 | 3.23 | 0.13 |
| EPS Diluted Continuous Ops | -0.44 | -0.65 | -0.49 | 3.22 | 0.13 |
| EPS Diluted Before Non-Recurring Items | -0.45 | -0.66 | -0.49 | -0.27 | 0.13 |
| EBITDA(a) | $-6,376 | $-5,549 | $-5,841 | $-5,485 | $-5,248 |